Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD

F. Grewe (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), M. Bradicich (Zurich, Switzerland), M. Roeder (Zurich, Switzerland), T. Brack (Glarus, Switzerland), M. Brutsche (St. Gallen, Switzerland), M. Frey (Barmelweid, Switzerland), S. Irani (Aarau, Switzerland), J. Leuppi (Basel, Switzerland), R. Turnheer (Münsterlingen, Switzerland), C. Clarenbach (Zurich, Switzerland), M. Kohler (Zurich, Switzerland)

Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Session: Inhaler devices in COPD: technical advances, adherence studies and more
Session type: E-poster session
Number: 646
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Grewe (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), M. Bradicich (Zurich, Switzerland), M. Roeder (Zurich, Switzerland), T. Brack (Glarus, Switzerland), M. Brutsche (St. Gallen, Switzerland), M. Frey (Barmelweid, Switzerland), S. Irani (Aarau, Switzerland), J. Leuppi (Basel, Switzerland), R. Turnheer (Münsterlingen, Switzerland), C. Clarenbach (Zurich, Switzerland), M. Kohler (Zurich, Switzerland). Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD. 646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study
Source: Annual Congress 2010 - Management of airway disease
Year: 2010


Compliance of COPD patients to their treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 244s
Year: 2003

Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018


Attention to ACOS in patients with asthma and COPD:Results from a national- multicentered study
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Real-life study on the aPpropriaTeness of treatment in moderate COPD patients (OPTIMO)
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Triple therapy de-escalation to dual bronchodilation in COPD patients: Baseline data from the DACCORD cohort
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


Costs and effects of structured COPD care – An observational, matched-cohort study
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013

Acute exacerbation of COPD patients therapy priorities: A survey study
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021


Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study
Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2014

Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Evaluation of adherence to medication treatment in pediatric patients with cystic fibrosis; a cross-sectional study
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Multicentre comparison of self-management in patients with COPD
Source: ERJ Open Res, 7 (3) 00252-2021; 10.1183/23120541.00252-2021
Year: 2021



Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx)
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020




Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018